EXOME ASSET MANAGEMENT LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}
{{ Info.Homepage }}

Adviser Profile

As of Date:

03/28/2024

Adviser Type:

- Large advisory firm

Number of Employees:

9 -10.00%

of those in investment advisory functions:

5 -16.67%

Registration:

SEC, Approved, 7/28/2021

Other registrations (1)
Former registrations

EXOME ASSET MANAGEMENT LLC

AUM:

181,836,994 0.80%

of that, discretionary:

181,836,994 0.80%

Private Fund GAV:

165,843,628 15.64%

Avg Account Size:

36,367,399 0.80%

SMA’s:

NO

Private Funds:

2

Contact Info

212 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
191M 164M 136M 109M 82M 55M 27M
2021 2022 2023

Recent News

Exome Asset Management Shortlisted for HFM's Sector Specialist and Emerging ... - Business Wire
08/30/2022

The awards recognize hedge fund, CTA and fund of hedge fund performance, encompassing the whole breadth of hedge fund strategy, from credit and equity ...

businesswire.com

Exome Asset Management Shortlisted for HFM's Best Newcomer Award | Business Wire
09/30/2021

The awards recognize hedge fund, CTA and fund of hedge fund performance, ... Exome practices two active investment strategies: one which invests broadly ...

businesswire.com


Private Funds Structure

Fund Type Count GAV
Hedge Fund 2 $165,843,628

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
CHESAPEAKE CAPITAL CORPORATION 80.7m - - - - - - 80.7m 201.9m 1
CONSTELLATION CAPITAL MANAGEMENT LLC - - - - - - - - 217.1m -
HIGHLAND PEAK CAPITAL, LLC 89.5m - - - - - - 89.5m 245.2m 2
EFS ASSET MANAGEMENT LLC - - - - - - - - 69.7m -
HURRICANE CAPITAL ADVISORS LLC 415.2m - - - - - - 415.2m 415.2m 17
STAINES FINANCIAL, LLC 46.4m - - - - - - 46.4m 181.9m 2
ADVISOR.INVESTMENTS 5.1m - - - - - - 5.1m 185.8m 1
ROUBAIX CAPITAL, LLC 128.0m - - - - - - 128.0m 199.0m 2
SPARROW CAPITAL MANAGEMENT INC 7.0m - - - - - - 7.0m 196.1m 1
FRIESS ASSOCIATES, LLC - - - - - - - - 181.9m -

Private Funds



Employees




Brochure Summary

Overview

Exome is a Delaware limited liability company with its principal place of business in New York. Exome was formed in 2018 and commenced investment advisory operations in June 2019. Exome was founded by its principal owner Samuel D. Isaly, who is the Managing Partner. Mr. Isaly owns his interest in Exome directly through a limited liability company. Exome provides discretionary investment advisory services to private funds: Emerging Markets Healthcare Partners LLC, a Delaware limited liability company, and Worldwide Healthcare Partners LLC, a Delaware limited liability company (collectively with Emerging Markets Healthcare Partners LLC the “Onshore Funds”), as well as Emerging Markets Healthcare Partners International Ltd, a Cayman Islands exempted company, and Worldwide Healthcare Partners International Ltd, a Cayman Islands exempted company (the “Offshore Funds” and collectively with the Onshore Funds the “Fund” or “Funds”). Exome Asset GP LLC (the “Managing Member”), which is a related entity of Exome, serves as the Managing Member to the Onshore Funds. In addition, Exome also provides discretionary investment sub-advisory services to a pooled investment vehicle (“Sub-Advised Fund”). Exome has in place an investment management agreement with each of the private funds, as
well as the Sub-Advised Funds. Exome is responsible for determining the specific securities and other investments to be bought and sold and arranging the execution of all purchase and sale orders on behalf of the Funds. Exome’s advisory services are provided to Funds pursuant to the terms of the Funds’ private placement memorandum, operating agreement, limited partnership agreement, sub-advisory agreement, and/or investment management agreement, as applicable (collectively, the “Governing Documents”) and based on the specific investment objectives and strategies as disclosed therein. Please refer to ITEM 8 methods of analysis, investment strategies, and risks of loss. Exome generally does not permit investors in the Funds to impose limitations on the investment activities described in the offering documents for the Exome Funds. Under certain circumstances, Exome will contract with a client to adhere to the limited risk and/or operating guidelines imposed by the client. Exome negotiates such arrangements on a case-by-case basis. Exome does not participate in wrap-fee programs. As of December 31, 2023, Exome managed approximately $181,836,994 of client regulatory assets on a discretionary basis. Exome does not currently manage any client assets on a non- discretionary basis.